Cargando…
Glutamate dehydrogenase hyperinsulinism: mechanisms, diagnosis, and treatment
Congenital hyperinsulinism (CHI) is a genetically heterogeneous disease, in which intractable, persistent hypoglycemia is induced by excessive insulin secretion and increased serum insulin concentration. To date,15 genes have been found to be associated with the pathogenesis of CHI. Glutamate dehydr...
Autores principales: | Zeng, Qiao, Sang, Yan-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887739/ https://www.ncbi.nlm.nih.gov/pubmed/36721237 http://dx.doi.org/10.1186/s13023-023-02624-6 |
Ejemplares similares
-
Genetic pathogenesis, diagnosis, and treatment of short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism
por: Zhang, Wei, et al.
Publicado: (2021) -
Congenital Hyperinsulinism: Diagnosis and Treatment Update
por: Demirbilek, Hüseyin, et al.
Publicado: (2017) -
OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019) -
The molecular mechanisms, diagnosis and management of congenital hyperinsulinism
por: Senniappan, Senthil, et al.
Publicado: (2013) -
Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase
por: Luczkowska, Karolina, et al.
Publicado: (2020)